TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL RESPIRATORY THERAPIES MARKET, BY TYPE
6.1. Overview
6.2. Diagnostic and Monitoring Devices
6.2.1. Spirometers
6.2.2. Sleep Test Devices
6.2.3. Peak Flow Meters
6.2.4. Pulse Oximeters
6.2.5. Capnographs
6.2.6. Other Diagnostic and Monitoring Devices
6.3. Therapeutic Devices
6.3.1. CPAP Devices
6.3.2. BiPAP Devices
6.3.3. Humidifiers
6.3.4. Nebulizers
6.3.5. Oxygen Concentrators
6.3.6. Ventilators
6.3.7. Inhalers
6.3.8. Other Therapeutic Devices
6.4. Disposables
6.4.1. Masks
6.4.2. Breathing Circuits
6.4.3. Other Disposables
7. GLOBAL RESPIRATORY THERAPIES MARKET, BY REGION
7.1. Overview
7.1. North America
7.1.1. US
7.1.2. Canada
7.2. Europe
7.2.1. Germany
7.2.2. France
7.2.3. UK
7.2.4. Italy
7.2.5. Spain
7.2.6. Rest of Europe
7.3. Asia-Pacific
7.3.1. China
7.3.2. India
7.3.3. Japan
7.3.4. South Korea
7.3.5. Australia
7.3.6. Rest of Asia-Pacific
7.4. Rest of the World
7.4.1. Middle East
7.4.2. Africa
7.4.3. Latin America
8. COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Competitive Analysis
8.3. Market Share Analysis
8.4. Major Growth Strategy in the Global Respiratory Therapies Market,
8.5. Competitive Benchmarking
8.6. Leading Players in Terms of Number of Developments in the Global Respiratory Therapies Market,
8.7. Key developments and Growth Strategies
8.7.1. New Product Launch/Service Deployment
8.7.2. Merger & Acquisitions
8.7.3. Joint Ventures
8.8. Major Players Financial Matrix
8.8.1. Sales & Operating Income, 2023
8.8.2. Major Players R&D Expenditure. 2023
9. COMPANY PROFILES
9.1. Philips Respironics
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Products Offered
9.1.4. Key Developments
9.1.5. SWOT Analysis
9.1.6. Key Strategies
9.2. ResMed Inc.
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Products Offered
9.2.4. Key Developments
9.2.5. SWOT Analysis
9.2.6. Key Strategies
9.3. Medtronic plc
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Products Offered
9.3.4. Key Developments
9.3.5. SWOT Analysis
9.3.6. Key Strategies
9.4. Fisher & Paykel Healthcare
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Products Offered
9.4.4. Key Developments
9.4.5. SWOT Analysis
9.4.6. Key Strategies
9.5. Masimo Corporation
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Products Offered
9.5.4. Key Developments
9.5.5. SWOT Analysis
9.5.6. Key Strategies
9.6. Hamilton Medical
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Products Offered
9.6.4. Key Developments
9.6.5. SWOT Analysis
9.6.6. Key Strategies
9.7. Vyaire Medical
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Products Offered
9.7.4. Key Developments
9.7.5. SWOT Analysis
9.7.6. Key Strategies
9.8. Smiths Medical
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Products Offered
9.8.4. Key Developments
9.8.5. SWOT Analysis
9.8.6. Key Strategies
9.9. DRÄGERWERK AG & CO. KGAA
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Products Offered
9.9.4. Key Developments
9.9.5. SWOT Analysis
9.9.6. Key Strategies
9.10. GE Healthcare
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Products Offered
9.10.4. Key Developments
9.10.5. SWOT Analysis
9.10.6. Key Strategies
10. APPENDIX
10.1. References
10.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL RESPIRATORY THERAPIES MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL RESPIRATORY THERAPIES MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 4 NORTH AMERICA: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 5 US: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 6 CANADA: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 2 GERMANY: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 3 FRANCE: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 4 ITALY: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 5 SPAIN: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 6 UK: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 7 REST OF EUROPE: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 8 ASIA-PACIFIC: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 9 JAPAN: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 10 CHINA: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 11 INDIA: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 12 AUSTRALIA: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 13 SOUTH KOREA: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 14 REST OF ASIA-PACIFIC: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 15 REST OF THE WORLD: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 16 MIDDLE EAST: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 17 AFRICA: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 18 LATIN AMERICA: RESPIRATORY THERAPIES MARKET, BY TYPE, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL RESPIRATORY THERAPIES MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL RESPIRATORY THERAPIES MARKET
FIGURE 4 GLOBAL RESPIRATORY THERAPIES MARKET, SHARE (%), BY TYPE, 2023
FIGURE 5 GLOBAL RESPIRATORY THERAPIES MARKET, SHARE (%), BY REGION, 2023
FIGURE 6 NORTH AMERICA: RESPIRATORY THERAPIES MARKET, SHARE (%), BY REGION, 2023
FIGURE 7 EUROPE: RESPIRATORY THERAPIES MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 ASIA-PACIFIC: RESPIRATORY THERAPIES MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 REST OF THE WORLD: RESPIRATORY THERAPIES MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 GLOBAL RESPIRATORY THERAPIES MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 11 PHILIPS RESPIRONICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 12 PHILIPS RESPIRONICS: SWOT ANALYSIS
FIGURE 13 RESMED INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 RESMED INC.: SWOT ANALYSIS
FIGURE 15 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 MEDTRONIC PLC: SWOT ANALYSIS
FIGURE 17 FISHER & PAYKEL HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 FISHER & PAYKEL HEALTHCARE: SWOT ANALYSIS
FIGURE 19 MASIMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 MASIMO CORPORATION: SWOT ANALYSIS
FIGURE 21 HAMILTON MEDICAL: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 HAMILTON MEDICAL: SWOT ANALYSIS
FIGURE 23 VYAIRE MEDICAL: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 VYAIRE MEDICAL: SWOT ANALYSIS
FIGURE 25 SMITHS MEDICAL: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 SMITHS MEDICAL: SWOT ANALYSIS
FIGURE 27 DRÄGERWERK AG & CO. KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 DRÄGERWERK AG & CO. KGAA: SWOT ANALYSIS
FIGURE 29 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 GE HEALTHCARE: SWOT ANALYSIS